Aspirin rarely used for colorectal cancer prevention
A study of 539 people with Lynch syndrome in Germany reveals that fewer than 10% use aspirin for colorectal cancer prevention. While research suggests low-dose aspirin may reduce cancer risk with fewer side effects, patient uptake remains low.
Why it matters
Improving awareness and adoption of low-dose aspirin could significantly reduce cancer mortality rates in high-risk populations.
edited by Gaby Clark , reviewed by Andrew Zinin
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in